Intercontinental Exchange CTO sells 4,272 shares

Q: How many ICE shares did Chief Technology Officer Mayur Kapani sell?

Mayur Kapani sold 4,272 ICE common shares on November 11, 2026, in four reported transactions. Transaction rows show prices of $176.90, $178.1685, $179.6980 and $180.3121 per share; the corresponding aggregate sale-price ranges were $176.55–$177.15, $177.81–$178.80, $179.18–$180.17 and $180.22–$180.50. The sales were under a Rule 10b5-1 plan approved and effective February 12, 2026.

Q: How many ICE shares did Mayur Kapani receive from option exercises?

Mayur Kapani exercised options covering 5,764 ICE common shares on November 11, 2026, at a $67 per-share exercise price. The option records show 4,272 and 1,492 shares, and both list an expiration date of February 8, 2028.

Available on EDGAR 11/13/2026 - 04:31 PM EST Accepted by SEC EDGAR 11/13/2026 - 04:30 PM EST

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Intercontinental Exchange, Inc. (ICE) Chief Technology Officer Mayur Kapani exercised options for 5,764 common shares on November 11, 2026, at a $67 exercise price, and sold 4,272 shares in four transactions that day at reported per-share prices ranging from $176.90 to $180.3121. The reported sales were under a Rule 10b5-1 plan approved and effective February 12, 2026.

Insider Trade Summary 10b5-1

Exercise and sale activity reported; no spread calculated

Exercise and Sale 8 txns

Insider Kapani Mayur

Role Chief Technology Officer

Sold 4,272 shs ($765K)

Approx. gross sale proceeds $765K

Approx. exercise cost $386K

Type	Security	Shares	Price	Value
Exercise	Employee Stock Option (right to buy) Holding ^F9	4,272	$0.00	$0.00
Exercise	Employee Stock Option (right to buy) Holding ^F9	1,492	$0.00	$0.00
Exercise	Common Stock ^F1	4,272	$67.00	$286K
Exercise	Common Stock	1,492	$67.00	$100K
Sale	Common Stock ^{F1, F2}	400	$176.90	$71K
Sale	Common Stock ^{F1, F3}	1,300	$178.1685	$232K
Sale	Common Stock ^{F1, F4}	2,000	$179.698	$359K
Sale	Common Stock ^{F1, F5, F6, F7, F8}	572	$180.3121	$103K

Holdings After Transaction: Employee Stock Option (right to buy) Holding — 0 options (Direct); Common Stock — 69,480 shares (Direct)

Footnotes (9)

F1. This transaction was effected pursuant to a Rule 10b5-l trading plan which was approved and became effective as of February 12, 2026.
F2. The price range for the aggregate amount sold by the direct holder is $176.55 - $177.15. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
F3. The price range for the aggregate amount sold by the direct holder is $177.81 - $178.80. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
F4. The price range for the aggregate amount sold by the direct holder is $179.18 - $180.17. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
F5. The price range for the aggregate amount sold by the direct holder is $180.22 - $180.50. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
F6. The common stock number referred in Table I is an aggregate number and represents 58,271 shares of common stock, 8,907 unvested restricted stock units ("RSUs"), and 2,302 performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three-year period, in which 33.33% of the units vest each year.
F7. The satisfaction of the 2024, 2025 and 2026 three-year total shareholder return ("TSR") PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting. The satisfaction of the 2024, 2025 and 2026 three-year earnings before interest, taxes, depreciation, and amortization ("EBITDA") PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting.
F8. The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period.
F9. These options are fully vested.

Key Figures

Shares acquired through option exercises: 5,764 shares Option exercise price: $67 per share Shares sold: 4,272 shares +4 more

7 metrics

Shares acquired through option exercises 5,764 shares November 11, 2026

Option exercise price $67 per share Options exercised November 11, 2026

Shares sold 4,272 shares Four reported sales on November 11, 2026

Reported sale price (400 shares) $176.90 per share November 11, 2026; aggregate sale-price range $176.55–$177.15 per share

Reported sale price (1,300 shares) $178.1685 per share November 11, 2026; aggregate sale-price range $177.81–$178.80 per share

Reported sale price (2,000 shares) $179.6980 per share November 11, 2026; aggregate sale-price range $179.18–$180.17 per share

Reported sale price (572 shares) $180.3121 per share November 11, 2026; aggregate sale-price range $180.22–$180.50 per share

Key Terms

Rule 10b5-1 trading plan

1 terms

Rule 10b5-1 trading plan regulatory

"the sale transactions reported for November 11, 2026"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many ICE shares did Chief Technology Officer Mayur Kapani sell?

Mayur Kapani sold 4,272 ICE common shares on November 11, 2026, in four reported transactions. Transaction rows show prices of $176.90, $178.1685, $179.6980 and $180.3121 per share; the corresponding aggregate sale-price ranges were $176.55–$177.15, $177.81–$178.80, $179.18–$180.17 and $180.22–$180.50. The sales were under a Rule 10b5-1 plan approved and effective February 12, 2026.

How many ICE shares did Mayur Kapani receive from option exercises?

Mayur Kapani exercised options covering 5,764 ICE common shares on November 11, 2026, at a $67 per-share exercise price. The option records show 4,272 and 1,492 shares, and both list an expiration date of February 8, 2028.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kapani Mayur

(Last)

(First)

(Middle)

5660 NEW NORTHSIDE DRIVE

(Street)

ATLANTA

GEORGIA

30328

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Intercontinental Exchange, Inc. [ ICE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Technology Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
11/11/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	11/11/2026		M		4,272⁽¹⁾	A	$67	72,260	D
Common Stock	11/11/2026		M		1,492	A	$67	73,752	D
Common Stock	11/11/2026		S		400⁽¹⁾	D	$176.9⁽²⁾	73,352	D
Common Stock	11/11/2026		S		1,300⁽¹⁾	D	$178.1685⁽³⁾	72,052	D
Common Stock	11/11/2026		S		2,000⁽¹⁾	D	$179.698⁽⁴⁾	70,052	D
Common Stock	11/11/2026		S		572⁽¹⁾	D	$180.3121⁽⁵⁾	69,480⁽⁶⁾⁽⁷⁾⁽⁸⁾	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Employee Stock Option (right to buy) Holding	$67	11/11/2026		M			4,272	⁽⁹⁾	02/08/2028	Common Stock	4,272	$0	1,492	D
Employee Stock Option (right to buy) Holding	$67	11/11/2026		M			1,492	⁽⁹⁾	02/08/2028	Common Stock	1,492	$0	0	D

Explanation of Responses:

1. This transaction was effected pursuant to a Rule 10b5-l trading plan which was approved and became effective as of February 12, 2026.

2. The price range for the aggregate amount sold by the direct holder is $176.55 - $177.15. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

3. The price range for the aggregate amount sold by the direct holder is $177.81 - $178.80. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

4. The price range for the aggregate amount sold by the direct holder is $179.18 - $180.17. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

5. The price range for the aggregate amount sold by the direct holder is $180.22 - $180.50. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

6. The common stock number referred in Table I is an aggregate number and represents 58,271 shares of common stock, 8,907 unvested restricted stock units ("RSUs"), and 2,302 performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three-year period, in which 33.33% of the units vest each year.

7. The satisfaction of the 2024, 2025 and 2026 three-year total shareholder return ("TSR") PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting. The satisfaction of the 2024, 2025 and 2026 three-year earnings before interest, taxes, depreciation, and amortization ("EBITDA") PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting.

8. The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period.

9. These options are fully vested.

	/s/ Octavia N. Spencer, Attorney-in-fact	11/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR